No Decline in Cognition Scores in Patients with Mild Alzheimer's Disease Who Received Simufilam Continuously For 24 Months

ADAS-Cog Scores Were Stable in a Group of Patients with Mild Alzheimer’s Who Received Drug Candidate Simufilam Continuously, Baseline to Month 24.Mild Alzheimer’s Patients Who Received Simufilam...

Related Keywords

Texas ,United States ,Puerto Rico ,Canada ,South Korea ,Australia ,Remi Barbier ,Eric Schoen ,Suzanne Hendrix ,Cassava Sciences ,Pentara Corporation ,A Group ,Group Of Patients ,Cassava Sciences Inc ,Nasdaq ,National Institutes Of Health ,Cog Scores Were Stable ,Mild Alzheimer ,Group Average ,Simufilam Safe ,Full Analysis Set ,Cognition Maintenance Study ,Cassava Science ,More Information Contact ,Chief Financial ,Note Regarding Forward Looking Statements ,Private Securities Litigation Reform Act ,Annual Report ,National Institutes ,Markets ,